SCHEMBL24741045

SCHEMBL24741045

c1ccc(-c2nc3ccccc3nc2-c2ccc3c4c(cccc24)-c2cccc4oc5cccc-3c5c24)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.50
▸ L3MBTL1 Q9Y468 6/20 0.49
▸ KDM4E B2RXH2 7/20 0.46
▸ LMNA P02545 5/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ GAA P10253 2/20 0.46
▸ KMT2A Q03164 3/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ PKM P14618 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ ADORA2A P29274 1/20 0.37
▸ NUDT1 P36639 1/20 0.37
▸ AKT1 P31749 1/20 0.37
▸ AKT2 P31751 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ATM Q13315 1/20 0.36
▸ TLR9 Q9NR96 1/20 0.36
▸ DHODH Q02127 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23385028 0.90 L3MBTL1 (0.48) CYP1A2L3MBTL1KDM4ELMNAALDH1A1
SCHEMBL23546643 0.90 CYP1A2 (0.57) CYP1A2L3MBTL1KDM4ELMNAALDH1A1
SCHEMBL22879980 0.84 L3MBTL1 (0.48) CYP1A2L3MBTL1KDM4ELMNAALDH1A1
SCHEMBL23521572 0.83 CYP1A2 (0.44) CYP1A2L3MBTL1KDM4ELMNAALDH1A1
SCHEMBL22825149 0.83 MEN1 (0.47) CYP1A2L3MBTL1KDM4ELMNAALDH1A1
SCHEMBL23385022 0.83 L3MBTL1 (0.49) CYP1A2L3MBTL1KDM4ELMNAALDH1A1
SCHEMBL23385234 0.83 CYP1A2 (0.50) CYP1A2L3MBTL1KDM4ELMNAALDH1A1
SCHEMBL24741293 0.82 L3MBTL1 (0.48) CYP1A2L3MBTL1KDM4ELMNAALDH1A1
SCHEMBL24741098 0.82 CYP1A2 (0.49) CYP1A2L3MBTL1KDM4ELMNAALDH1A1
SCHEMBL23920326 0.81 L3MBTL1 (0.46) CYP1A2L3MBTL1KDM4ELMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220255017-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2022-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220255017-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, ICOSLG, TRPM4 CYP1A2 2492/4885L3MBTL1 462/4885KDM4E 1166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback